drugset / Trial / NCT02842099
Standard Chemotherapy Followed by Capecitabine as Prolonged Postoperative Adjuvant Treatment for Breast Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
The study is a prospective, randomized phase II clinical trial, to compare the efficacy and safety profiles of standard chemotherapy versus standard chemotherapy followed by capecitabine as prolonged postoperative adjuvant treatment for breast cancer patients.
Timeline
- Start
- 2014-01
- Primary completion
- 2020-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 2.5 g | Oral |
| Background | Cyclophosphamide | Other / unclassified | — | — |
| Background | Epirubincin | Unknown | — | — |
| Background | Paclitaxel | Small molecule | — | — |